| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Laetitia Minguez, Marie-Pierre Halm-Lemeille, Katherine Costil, Ronan Bureau, Jean-Marc Lebel, Antoine Serpentin. Assessment of cytotoxic and immunomodulatory properties of four antidepressants on primary cultures of abalone hemocytes (Haliotis tuberculata). Aquatic toxicology (Amsterdam, Netherlands). vol 153. 2014-08-01. PMID:24210974. |
overall, amitriptyline and clomipramine, the two tricyclic antidepressants, had higher immunomodulatory capacities than the two selective serotonin reuptake inhibitors citalopram and paroxetine. |
2014-08-01 |
2023-08-12 |
Not clear |
| Henricus G Ruhé, Michiel Koster, Jan Booij, Marcel van Herk, Dick J Veltman, Aart H Schen. Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder. Psychiatry research. vol 221. issue 2. 2014-07-28. PMID:24406081. |
occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder. |
2014-07-28 |
2023-08-12 |
Not clear |
| Henricus G Ruhé, Michiel Koster, Jan Booij, Marcel van Herk, Dick J Veltman, Aart H Schen. Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder. Psychiatry research. vol 221. issue 2. 2014-07-28. PMID:24406081. |
we hypothesized that higher amygdala serotonin transporter (sert) occupancy by paroxetine results in greater attenuation of amygdala activation by negative facial expressions in mdd patients. |
2014-07-28 |
2023-08-12 |
Not clear |
| Kevin T Fitzgerald, Alvin C Bronstei. Selective serotonin reuptake inhibitor exposure. Topics in companion animal medicine. vol 28. issue 1. 2014-07-10. PMID:23796482. |
the selective serotonin reuptake inhibitor class of antidepressants (ssris) includes citalopram, escitalopram (active enantiomer of citalopram), fluoxetine, fluvoxamine, paroxetine, and sertraline. |
2014-07-10 |
2023-08-12 |
Not clear |
| Kazuki Nagayasu, Maiko Kitaichi, Naoya Nishitani, Nozomi Asaoka, Hisashi Shirakawa, Takayuki Nakagawa, Shuji Kanek. Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release. The international journal of neuropsychopharmacology. vol 16. issue 10. 2014-07-01. PMID:23920436. |
recently, we reported that sustained exposure of rat organotypic raphe slice cultures containing abundant serotonergic neurons to selective serotonin (5-ht) reuptake inhibitors (citalopram, fluoxetine and paroxetine) caused the augmentation of exocytotic serotonin release. |
2014-07-01 |
2023-08-12 |
rat |
| F Rouillo. Depression comorbid with anxiety or medical illness: The role of paroxetine. International journal of psychiatry in clinical practice. vol 5. issue 1. 2014-06-19. PMID:24936987. |
the selective serotonin re-uptake inhibitor paroxetine has proven efficacy in the treatment of depression and anxiety disorders, including panic disorder, obsessive compulsive disorder and social anxiety disorder. |
2014-06-19 |
2023-08-13 |
Not clear |
| S Dorz Sabrina Cognolato Donatella Conforti Caterina Scarso Giuseppe Borgherin. A naturalistic study on the criteria of choice of second-generation antidepressants: A comparison of venlafaxine and SSRIs in depressed inpatients. International journal of psychiatry in clinical practice. vol 5. issue 3. 2014-06-17. PMID:24926750. |
the objective of this study was to compare, in a naturalistic setting, the efficacy and tolerability of selective serotonin reuptake inhibitors (paroxetine, sertraline, citalopram) and venlafaxine, in 120 depressed inpatients. |
2014-06-17 |
2023-08-13 |
Not clear |
| J Frölich Alfred Wiater Gerd Lehmkuh. Successful treatment of severe parasomnias with paroxetine in a 12-year-old boy. International journal of psychiatry in clinical practice. vol 5. issue 3. 2014-06-17. PMID:24926757. |
we report the case of a 12-year-old boy with severe night terrors and somnambulism whose symptoms completely remitted under medication with the selective serotonin re-uptake inhibitor paroxetine. |
2014-06-17 |
2023-08-13 |
Not clear |
| R J Boerner, H J Mölle. The value of selective serotonin re-uptake inhibitors (SSRIs) in the treatment of panic disorder with and without agoraphobia. International journal of psychiatry in clinical practice. vol 1. issue 1. 2014-06-17. PMID:24926982. |
this review represents a comprehensive survey of all existing studies of the efficacy of the selective serotonin re-uptake inhibitors (ssris) paroxetine and fluvoxamine. |
2014-06-17 |
2023-08-13 |
Not clear |
| Raymond W La. Generalized anxiety disorder: how to treat, and for how long? International journal of psychiatry in clinical practice. vol 10 Suppl 1. 2014-06-17. PMID:24931538. |
in placebo-controlled, acute (<8 weeks) trials, several medications, including the selective serotonin reuptake inhibitors ([ssris] escitalopram, paroxetine, and sertraline) and others (venlafaxine, buspirone, pregabalin), have demonstrated efficacy in patients with gad. |
2014-06-17 |
2023-08-13 |
Not clear |
| David S Baldwi. Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders. International journal of psychiatry in clinical practice. vol 10 Suppl 2. 2014-06-14. PMID:24921677. |
the probable role of disturbed serotonergic neurotransmission in anxiety is widely accepted and is the theoretical basis for the use of serotonergic agents such as the 5-ht1a receptor partial agonist, buspirone, and the selective serotonin reuptake inhibitors (ssri), such as sertraline and paroxetine, which have largely replaced the earlier antidepressants. |
2014-06-14 |
2023-08-13 |
Not clear |
| L P Kaspe. Paroxetine in panic disorder with agoraphobia. International journal of psychiatry in clinical practice. vol 5. issue 4. 2014-06-14. PMID:24921696. |
a case of a panic disorder patient treated successfully in the long term with a selective serotonin re-uptake inhibitor, paroxetine, is reported. |
2014-06-14 |
2023-08-13 |
Not clear |
| Kengo Shimoda, Mahito Kimur. Two cases of emotional disorder after middle cerebral artery infarction showing distinct responses to antidepressant treatment. Neuropsychiatric disease and treatment. vol 10. 2014-06-13. PMID:24926198. |
both patients were initially treated with the selective serotonin reuptake inhibitor (ssri) paroxetine. |
2014-06-13 |
2023-08-13 |
Not clear |
| Chittaranjan Andrad. Antidepressants and testicular cancer: cause versus association. The Journal of clinical psychiatry. vol 75. issue 3. 2014-06-10. PMID:24717391. |
a data mining study that examined associations between 105 drugs and 55 cancer sites found significant associations between 2 selective serotonin reuptake inhibitors (fluoxetine and paroxetine) and testicular cancer. |
2014-06-10 |
2023-08-13 |
Not clear |
| Christian Webhofer, Philipp Gormanns, Stefan Reckow, Maria Lebar, Giuseppina Maccarrone, Tonia Ludwig, Benno Pütz, John M Asara, Florian Holsboer, Inge Sillaber, Walter Zieglgänsberger, Christoph W Turc. Proteomic and metabolomic profiling reveals time-dependent changes in hippocampal metabolism upon paroxetine treatment and biomarker candidates. Journal of psychiatric research. vol 47. issue 3. 2014-05-30. PMID:23207114. |
in the present study we aimed at identifying hippocampal cellular pathway alterations in dba/2 mice using paroxetine as a representative selective serotonin reuptake inhibitor (ssri). |
2014-05-30 |
2023-08-12 |
mouse |
| Mohammad M Herzallah, Ahmed A Moustafa, Joman Y Natsheh, Omar A Danoun, Jessica R Simon, Yasin I Tayem, Mahmud A Sehwail, Ivona Amleh, Issam Bannoura, Georgios Petrides, Catherine E Myers, Mark A Gluc. Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder. Journal of affective disorders. vol 151. issue 2. 2014-05-13. PMID:23953023. |
depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder. |
2014-05-13 |
2023-08-12 |
Not clear |
| Mohammad M Herzallah, Ahmed A Moustafa, Joman Y Natsheh, Omar A Danoun, Jessica R Simon, Yasin I Tayem, Mahmud A Sehwail, Ivona Amleh, Issam Bannoura, Georgios Petrides, Catherine E Myers, Mark A Gluc. Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder. Journal of affective disorders. vol 151. issue 2. 2014-05-13. PMID:23953023. |
to better understand how medication status and task demands affect cognition in major depressive disorder (mdd), we evaluated medication-naïve patients with mdd, medicated patients with mdd receiving the selective serotonin reuptake inhibitors (ssri) paroxetine, and healthy controls. |
2014-05-13 |
2023-08-12 |
Not clear |
| Li An, Priyadarshini P Ravindran, Swetha Renukunta, Srinivas Dendulur. Co-medication of pravastatin and paroxetine-a categorical study. Journal of clinical pharmacology. vol 53. issue 11. 2014-05-12. PMID:23907716. |
we report here the co-medication effects of pravastatin (hmg-coa reductase inhibitor) and paroxetine (selective serotonin reuptake inhibitor (ssri) anti-depressant) on significant clinical parameters, identified through a data mining analysis conducted on the allscripts data warehouse. |
2014-05-12 |
2023-08-12 |
Not clear |
| Charles R Ashby, John H Kehne, Gerd D Bartoszyk, Matthew J Renda, Maria Athanasiou, Kerri A Pierz, Christoph A Seyfrie. Electrophysiological evidence for rapid 5-HT₁A autoreceptor inhibition by vilazodone, a 5-HT₁A receptor partial agonist and 5-HT reuptake inhibitor. European journal of pharmacology. vol 714. issue 1-3. 2014-05-06. PMID:23872377. |
this study examined the effect of vilazodone, a combined serotonin (5-ht) reuptake inhibitor and 5-ht(1a) receptor partial agonist, paroxetine and fluoxetine on the sensitivity of 5-ht(1a) autoreceptors of serotonergic dorsal raphe nucleus neurons in rats. |
2014-05-06 |
2023-08-12 |
rat |
| Charles R Ashby, John H Kehne, Gerd D Bartoszyk, Matthew J Renda, Maria Athanasiou, Kerri A Pierz, Christoph A Seyfrie. Electrophysiological evidence for rapid 5-HT₁A autoreceptor inhibition by vilazodone, a 5-HT₁A receptor partial agonist and 5-HT reuptake inhibitor. European journal of pharmacology. vol 714. issue 1-3. 2014-05-06. PMID:23872377. |
in contrast, paroxetine and fluoxetine at doses that were supramaximal for 5-ht uptake inhibition did not significantly alter the id₅₀ value of 8-oh-dpat after acute or subchronic administration. |
2014-05-06 |
2023-08-12 |
rat |